{"id":233321,"date":"2026-09-07T13:02:28","date_gmt":"2026-09-07T07:32:28","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=233321"},"modified":"2026-09-07T13:02:30","modified_gmt":"2026-09-07T07:32:30","slug":"amrutanjan-health-care-share-price-buy-hold-or-sell","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/amrutanjan-health-care-share-price-buy-hold-or-sell\/","title":{"rendered":"Amrutanjan Health Care: Should You Buy, Hold, or Sell Right Now?"},"content":{"rendered":"

Amrutanjan Health Care share price Rs 496.85 (NSE), near its 52-week low. 52-week range Rs 482.65 to Rs 790.95. Trades at a discount of 27.12 times earnings.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Amrutanjan Health Care Ltd share price is trading around Rs 497, close to its 52-week low of Rs 482.65 and more than 37 percent below its 52-week high of Rs 790.95. This consumer healthcare company, known for its Amrutanjan balm, trades at a price to earnings ratio of 27.12, a discount to the pharma and consumer healthcare sector average near 50.8 times, with a return on equity of 17.42 percent and a debt-free balance sheet. Current-quarter financial data was not consistently available across public sources at the time of writing, so this article relies on the most recently available trailing metrics and flags the stock’s sharp decline from its 52-week high as worth investigating further.<\/p>\n<\/div>\n

Amrutanjan Health Care share price has fallen more than 37 percent from its 52-week high of Rs 790.95, with Amrutanjan Health Care share price now trading near Rs 497 on the NSE, close to its 52-week low of Rs 482.65. Given the sharp decline alongside limited current-quarter data, this article presents the available valuation picture plainly before laying out a balanced view.<\/p>\n

This Amrutanjan Health Care overview walks through the available valuation data, the sharp decline from the 52-week high, shareholding pattern and the technical setup, using figures sourced from public filings, with appropriate caveats given the data limitations involved.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n